[
    [
        {
            "time": "",
            "original_text": "康龙化成现2笔大宗交易 ，共成交9,062.40万元",
            "features": {
                "keywords": [
                    "康龙化成",
                    "大宗交易",
                    "成交额"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "康龙化成现2笔大宗交易 ，共成交9,062.40万元",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 4,
                "Duration": 3,
                "Entity_Density": 10,
                "Market_Scope": 2,
                "Time_Proximity": 7,
                "Headline_Structure": 5,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "康龙化成(03759.HK)3Q20业绩：利润率持续提升，维持“买入”评级，目标价135.0港元",
            "features": {
                "keywords": [
                    "康龙化成",
                    "业绩",
                    "利润率",
                    "买入评级",
                    "目标价"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "康龙化成(03759.HK)3Q20业绩：利润率持续提升，维持“买入”评级，目标价135.0港元",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 2,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "医药生物行业上市公司2020年三季报小结：疫情影响逐渐消退 关注高成长大龙头+细分冠军",
            "features": {
                "keywords": [
                    "医药生物",
                    "三季报",
                    "疫情影响",
                    "高成长",
                    "龙头"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药生物行业上市公司2020年三季报小结：疫情影响逐渐消退 关注高成长大龙头+细分冠军",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "【异动股】康龙化成(03759-HK)涨3.42%",
            "features": {
                "keywords": [
                    "康龙化成",
                    "股价上涨",
                    "异动"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【异动股】康龙化成(03759-HK)涨3.42%",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 8,
                "Duration": 2,
                "Entity_Density": 10,
                "Market_Scope": 2,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "快讯：港股医药股集体上涨 药明巨诺涨超8%康龙化成涨近5%",
            "features": {
                "keywords": [
                    "港股",
                    "医药股",
                    "集体上涨",
                    "药明巨诺",
                    "康龙化成"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "快讯：港股医药股集体上涨 药明巨诺涨超8%康龙化成涨近5%",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 7,
                "Duration": 2,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "商业模式：「里程碑」付款模式和「风险共担，利益共享」模式为主",
            "features": {
                "keywords": [
                    "商业模式",
                    "里程碑",
                    "风险共担",
                    "利益共享"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "商业模式：「里程碑」付款模式和「风险共担，利益共享」模式为主",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 4,
                "Impact": 3,
                "Duration": 4,
                "Entity_Density": 3,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 4,
                "Source_Recency": 8
            }
        }
    ]
]